LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 10

Search options

  1. Article: Primary cilia suppress Ripk3-mediated necroptosis.

    Kieckhöfer, Emilia / Slaats, Gisela G / Ebert, Lena K / Albert, Marie-Christine / Dafinger, Claudia / Kashkar, Hamid / Benzing, Thomas / Schermer, Bernhard

    Cell death discovery

    2022  Volume 8, Issue 1, Page(s) 477

    Abstract: Cilia are sensory organelles that project from the surface of almost all cells. Nephronophthisis (NPH) and NPH-related ciliopathies are degenerative genetic diseases caused by mutation of cilia-associated genes. These kidney disorders are characterized ... ...

    Abstract Cilia are sensory organelles that project from the surface of almost all cells. Nephronophthisis (NPH) and NPH-related ciliopathies are degenerative genetic diseases caused by mutation of cilia-associated genes. These kidney disorders are characterized by progressive loss of functional tubular epithelial cells which is associated with inflammation, progressive fibrosis, and cyst formation, ultimately leading to end-stage renal disease. However, disease mechanisms remain poorly understood. Here, we show that targeted deletion of cilia in renal epithelial cells enhanced susceptibility to necroptotic cell death under inflammatory conditions. Treatment of non-ciliated cells with tumor necrosis factor (TNF) α and the SMAC mimetic birinapant resulted in Ripk1-dependent cell death, while viability of ciliated cells was almost not affected. Cell death could be enhanced and shifted toward necroptosis by the caspase inhibitor emricasan, which could be blocked by inhibitors of Ripk1 and Ripk3. Moreover, combined treatment of ciliated and non-ciliated cells with TNFα and cycloheximide induced a cell death response that could be partially rescued with emricasan in ciliated cells. In contrast, non-ciliated cells responded with pronounced cell death that was blocked by necroptosis inhibitors. Consistently, combined treatment with interferon-γ and emricasan induced cell death only in non-ciliated cells. Mechanistically, enhanced necroptosis induced by loss of cilia could be explained by induction of Ripk3 and increased abundance of autophagy components, including p62 and LC3 associated with the Ripk1/Ripk3 necrosome. Genetic ablation of cilia in renal tubular epithelial cells in mice resulted in TUNEL positivity and increased expression of Ripk3 in kidney tissue. Moreover, loss of Nphp1, the most frequent cause of NPH, further increased susceptibility to necroptosis in non-ciliated epithelial cells, suggesting that necroptosis might contribute to the pathogenesis of the disease. Together, these data provide a link between cilia-related signaling and cell death responses and shed new light on the disease pathogenesis of NPH-related ciliopathies.
    Language English
    Publishing date 2022-12-02
    Publishing country United States
    Document type Journal Article
    ISSN 2058-7716
    ISSN 2058-7716
    DOI 10.1038/s41420-022-01272-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: CHIP ubiquitylates NOXA and induces its lysosomal degradation in response to DNA damage.

    Albert, Marie-Christine / Brinkmann, Kerstin / Pokrzywa, Wojciech / Günther, Saskia Diana / Krönke, Martin / Hoppe, Thorsten / Kashkar, Hamid

    Cell death & disease

    2020  Volume 11, Issue 9, Page(s) 740

    Abstract: The BH3-only protein NOXA is a regulator of mitochondrial apoptosis by specifically antagonizing the anti-apoptotic protein MCL-1. Here we show that the E3 ubiquitin ligase CHIP controls NOXA stability after DNA damage. Our findings reveal that CHIP and ... ...

    Abstract The BH3-only protein NOXA is a regulator of mitochondrial apoptosis by specifically antagonizing the anti-apoptotic protein MCL-1. Here we show that the E3 ubiquitin ligase CHIP controls NOXA stability after DNA damage. Our findings reveal that CHIP and MCL-1 are binding partners of NOXA and differentially define the fate of NOXA. Whereas NOXA is initially targeted to mitochondria upon MCL-1-binding, CHIP mediates ubiquitylation of cytosolic NOXA and promotes lysosomal degradation of NOXA, which is not bound by MCL-1. Our data indicate that MCL-1 defines NOXA abundance and its pro-apoptotic activity. Increased NOXA levels beyond this threshold are effectively removed by lysosomal protein degradation triggered via CHIP-mediated ubiquitylation. Together, these results shed new light on regulatory circuits controlling DNA damage response and identified the E3 ligase CHIP as a new molecular guardian, which restricts the cytosolic accumulation of NOXA upon genotoxic stress.
    MeSH term(s) DNA Damage/genetics ; Humans ; Lysosomes/metabolism ; Ubiquitin-Protein Ligases/metabolism ; Ubiquitination/genetics
    Chemical Substances STUB1 protein, human (EC 2.3.2.27) ; Ubiquitin-Protein Ligases (EC 2.3.2.27)
    Language English
    Publishing date 2020-09-10
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2541626-1
    ISSN 2041-4889 ; 2041-4889
    ISSN (online) 2041-4889
    ISSN 2041-4889
    DOI 10.1038/s41419-020-02923-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Noxa and cancer therapy: Tuning up the mitochondrial death machinery in response to chemotherapy.

    Albert, Marie-Christine / Brinkmann, Kerstin / Kashkar, Hamid

    Molecular & cellular oncology

    2014  Volume 1, Issue 1, Page(s) e29906

    Abstract: Biochemical analyses have characterized the BH3-only protein family member Noxa as a "sensitizer" with weak pro-apoptotic activity. Investigations into cancer cell responses to chemotherapeutic agents have identified Noxa as a pivotal factor mediating ... ...

    Abstract Biochemical analyses have characterized the BH3-only protein family member Noxa as a "sensitizer" with weak pro-apoptotic activity. Investigations into cancer cell responses to chemotherapeutic agents have identified Noxa as a pivotal factor mediating the cytotoxic effect of a plethora of anticancer treatments independent of its own pro-apoptotic activity. Accumulating evidence now suggests that tumor cells exert a number of strategies to counteract Noxa function by exploiting diverse cellular regulatory circuits that normally govern Noxa expression during cellular stress responses. Here, we summarize data concerning the role of Noxa in cancer chemosensitivity and highlight the potential of this enigmatic BH3-only protein family member in current and novel anticancer therapies.
    Language English
    Publishing date 2014-07-28
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 2372-3556
    ISSN 2372-3556
    DOI 10.4161/mco.29906
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccination.

    Theobald, Sebastian J / Simonis, Alexander / Mudler, Julie M / Göbel, Ulrike / Acton, Richard / Kohlhas, Viktoria / Albert, Marie-Christine / Hellmann, Anna-Maria / Malin, Jakob J / Winter, Sandra / Hallek, Michael / Walczak, Henning / Nguyen, Phuong-Hien / Koch, Manuel / Rybniker, Jan

    EMBO molecular medicine

    2022  Volume 14, Issue 8, Page(s) e15888

    Abstract: Durable cell-mediated immune responses require efficient innate immune signaling and the release of pro-inflammatory cytokines. How precisely mRNA vaccines trigger innate immune cells for shaping antigen specific adaptive immunity remains unknown. Here, ... ...

    Abstract Durable cell-mediated immune responses require efficient innate immune signaling and the release of pro-inflammatory cytokines. How precisely mRNA vaccines trigger innate immune cells for shaping antigen specific adaptive immunity remains unknown. Here, we show that SARS-CoV-2 mRNA vaccination primes human monocyte-derived macrophages for activation of the NLRP3 inflammasome. Spike protein exposed macrophages undergo NLRP3-driven pyroptotic cell death and subsequently secrete mature interleukin-1β. These effects depend on activation of spleen tyrosine kinase (SYK) coupled to C-type lectin receptors. Using autologous cocultures, we show that SYK and NLRP3 orchestrate macrophage-driven activation of effector memory T cells. Furthermore, vaccination-induced macrophage priming can be enhanced with repetitive antigen exposure providing a rationale for prime-boost concepts to augment innate immune signaling in SARS-CoV-2 vaccination. Collectively, these findings identify SYK as a regulatory node capable of differentiating between primed and unprimed macrophages, which modulate spike protein-specific T cell responses.
    MeSH term(s) COVID-19/prevention & control ; COVID-19 Vaccines ; Humans ; Immunity, Innate ; Inflammasomes/metabolism ; Interleukin-1beta ; Intracellular Signaling Peptides and Proteins/genetics ; NLR Family, Pyrin Domain-Containing 3 Protein ; Protein-Tyrosine Kinases/metabolism ; RNA, Messenger/genetics ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus/genetics ; Syk Kinase ; Vaccination
    Chemical Substances COVID-19 Vaccines ; Inflammasomes ; Interleukin-1beta ; Intracellular Signaling Peptides and Proteins ; NLR Family, Pyrin Domain-Containing 3 Protein ; RNA, Messenger ; Spike Glycoprotein, Coronavirus ; spike protein, SARS-CoV-2 ; Protein-Tyrosine Kinases (EC 2.7.10.1) ; Syk Kinase (EC 2.7.10.2)
    Language English
    Publishing date 2022-07-04
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2467145-9
    ISSN 1757-4684 ; 1757-4676
    ISSN (online) 1757-4684
    ISSN 1757-4676
    DOI 10.15252/emmm.202215888
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: BCL-2-family protein tBID can act as a BAX-like effector of apoptosis.

    Flores-Romero, Hector / Hohorst, Lisa / John, Malina / Albert, Marie-Christine / King, Louise E / Beckmann, Laura / Szabo, Tamas / Hertlein, Vanessa / Luo, Xu / Villunger, Andreas / Frenzel, Lukas P / Kashkar, Hamid / Garcia-Saez, Ana J

    The EMBO journal

    2021  Volume 41, Issue 2, Page(s) e108690

    Abstract: During apoptosis, the BCL-2-family protein tBID promotes mitochondrial permeabilization by activating BAX and BAK and by blocking anti-apoptotic BCL-2 members. Here, we report that tBID can also mediate mitochondrial permeabilization by itself, resulting ...

    Abstract During apoptosis, the BCL-2-family protein tBID promotes mitochondrial permeabilization by activating BAX and BAK and by blocking anti-apoptotic BCL-2 members. Here, we report that tBID can also mediate mitochondrial permeabilization by itself, resulting in release of cytochrome c and mitochondrial DNA, caspase activation and apoptosis even in absence of BAX and BAK. This previously unrecognized activity of tBID depends on helix 6, homologous to the pore-forming regions of BAX and BAK, and can be blocked by pro-survival BCL-2 proteins. Importantly, tBID-mediated mitochondrial permeabilization independent of BAX and BAK is physiologically relevant for SMAC release in the immune response against Shigella infection. Furthermore, it can be exploited to kill leukaemia cells with acquired venetoclax resistance due to lack of active BAX and BAK. Our findings define tBID as an effector of mitochondrial permeabilization in apoptosis and provide a new paradigm for BCL-2 proteins, with implications for anti-bacterial immunity and cancer therapy.
    MeSH term(s) Apoptosis ; Apoptosis Regulatory Proteins/metabolism ; BH3 Interacting Domain Death Agonist Protein/chemistry ; BH3 Interacting Domain Death Agonist Protein/genetics ; BH3 Interacting Domain Death Agonist Protein/metabolism ; HCT116 Cells ; HeLa Cells ; Humans ; Mitochondria/metabolism ; Mitochondrial Proteins/metabolism ; Protein Domains ; Proteolysis ; Proto-Oncogene Proteins c-bcl-2/metabolism ; bcl-2 Homologous Antagonist-Killer Protein/metabolism ; bcl-2-Associated X Protein/metabolism
    Chemical Substances Apoptosis Regulatory Proteins ; BAK1 protein, human ; BCL2 protein, human ; BH3 Interacting Domain Death Agonist Protein ; DIABLO protein, human ; Mitochondrial Proteins ; Proto-Oncogene Proteins c-bcl-2 ; bcl-2 Homologous Antagonist-Killer Protein ; bcl-2-Associated X Protein
    Language English
    Publishing date 2021-12-21
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 586044-1
    ISSN 1460-2075 ; 0261-4189
    ISSN (online) 1460-2075
    ISSN 0261-4189
    DOI 10.15252/embj.2021108690
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality.

    Albert, Marie-Christine / Uranga-Murillo, Iratxe / Arias, Maykel / De Miguel, Diego / Peña, Natacha / Montinaro, Antonella / Varanda, Ana Beatriz / Theobald, Sebastian J / Areso, Itziar / Saggau, Julia / Koch, Manuel / Liccardi, Gianmaria / Peltzer, Nieves / Rybniker, Jan / Hurtado-Guerrero, Ramón / Merino, Pedro / Monzón, Marta / Badiola, Juan J / Reindl-Schwaighofer, Roman /
    Sanz-Pamplona, Rebeca / Cebollada-Solanas, Alberto / Megyesfalvi, Zsolt / Dome, Balazs / Secrier, Maria / Hartmann, Boris / Bergmann, Michael / Pardo, Julián / Walczak, Henning

    Cell death and differentiation

    2024  Volume 31, Issue 5, Page(s) 544–557

    Abstract: The dysregulated immune response and inflammation resulting in severe COVID-19 are still incompletely understood. Having recently determined that aberrant death-ligand-induced cell death can cause lethal inflammation, we hypothesized that this process ... ...

    Abstract The dysregulated immune response and inflammation resulting in severe COVID-19 are still incompletely understood. Having recently determined that aberrant death-ligand-induced cell death can cause lethal inflammation, we hypothesized that this process might also cause or contribute to inflammatory disease and lung failure following SARS-CoV-2 infection. To test this hypothesis, we developed a novel mouse-adapted SARS-CoV-2 model (MA20) that recapitulates key pathological features of COVID-19. Concomitantly with occurrence of cell death and inflammation, FasL expression was significantly increased on inflammatory monocytic macrophages and NK cells in the lungs of MA20-infected mice. Importantly, therapeutic FasL inhibition markedly increased survival of both, young and old MA20-infected mice coincident with substantially reduced cell death and inflammation in their lungs. Intriguingly, FasL was also increased in the bronchoalveolar lavage fluid of critically-ill COVID-19 patients. Together, these results identify FasL as a crucial host factor driving the immuno-pathology that underlies COVID-19 severity and lethality, and imply that patients with severe COVID-19 may significantly benefit from therapeutic inhibition of FasL.
    MeSH term(s) COVID-19/pathology ; COVID-19/immunology ; COVID-19/metabolism ; COVID-19/virology ; COVID-19/mortality ; Animals ; Fas Ligand Protein/metabolism ; Mice ; Humans ; SARS-CoV-2 ; Disease Models, Animal ; Lung/pathology ; Lung/virology ; Lung/metabolism ; Killer Cells, Natural/immunology ; Killer Cells, Natural/metabolism ; Mice, Inbred C57BL ; Female ; Male ; Inflammation/pathology ; Inflammation/metabolism ; Bronchoalveolar Lavage Fluid ; Macrophages/metabolism ; Macrophages/pathology
    Language English
    Publishing date 2024-03-21
    Publishing country England
    Document type Journal Article
    ZDB-ID 1225672-9
    ISSN 1476-5403 ; 1350-9047
    ISSN (online) 1476-5403
    ISSN 1350-9047
    DOI 10.1038/s41418-024-01278-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Immunological fingerprint in coronavirus disease-19 convalescents with and without post-COVID syndrome.

    Augustin, Max / Heyn, Ferdinand / Ullrich, Stella / Sandaradura de Silva, Ute / Albert, Marie-Christine / Linne, Viktoria / Schlotz, Maike / Schommers, Philipp / Pracht, Elisabeth / Horn, Carola / Suarez, Isabelle / Simonis, Alexander / Picard, Lea Katharina / Zoufaly, Alexander / Wenisch, Christoph / Fätkenheuer, Gerd / Gruell, Henning / Klein, Florian / Hallek, Michael /
    Walczak, Henning / Rybniker, Jan / Theobald, Sebastian J / Lehmann, Clara

    Frontiers in medicine

    2023  Volume 10, Page(s) 1129288

    Abstract: Background: Symptoms lasting longer than 12  weeks after severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection are called post-coronavirus disease (COVID) syndrome (PCS). The identification of new biomarkers that predict the ... ...

    Abstract Background: Symptoms lasting longer than 12  weeks after severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection are called post-coronavirus disease (COVID) syndrome (PCS). The identification of new biomarkers that predict the occurrence or course of PCS in terms of a post-viral syndrome is vital. T-cell dysfunction, cytokine imbalance, and impaired autoimmunity have been reported in PCS. Nevertheless, there is still a lack of conclusive information on the underlying mechanisms due to, among other things, a lack of controlled study designs.
    Methods: Here, we conducted a prospective, controlled study to characterize the humoral and cellular immune response in unvaccinated patients with and without PCS following SARS-CoV-2 infection over 7 months and unexposed donors.
    Results: Patients with PCS showed as early as 6 weeks and 7 months after symptom onset significantly increased frequencies of SARS-CoV-2-specific CD4
    Conclusion: This work describes immunological alterations between inflammation and immunosuppression in COVID-19 convalescents with and without PCS, which may provide potential directions for future epidemiological investigations and targeted treatments.
    Language English
    Publishing date 2023-04-24
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2775999-4
    ISSN 2296-858X
    ISSN 2296-858X
    DOI 10.3389/fmed.2023.1129288
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Cleavage of cFLIP restrains cell death during viral infection and tissue injury and favors tissue repair.

    Martinez Lagunas, Kristel / Savcigil, Deniz Pinar / Zrilic, Matea / Carvajal Fraile, Carlos / Craxton, Andrew / Self, Emily / Uranga-Murillo, Iratxe / de Miguel, Diego / Arias, Maykel / Willenborg, Sebastian / Piekarek, Michael / Albert, Marie Christine / Nugraha, Kalvin / Lisewski, Ina / Janakova, Erika / Igual, Natalia / Tonnus, Wulf / Hildebrandt, Ximena / Ibrahim, Mohammed /
    Ballegeer, Marlies / Saelens, Xavier / Kueh, Andrew / Meier, Pascal / Linkermann, Andreas / Pardo, Julian / Eming, Sabine / Walczak, Henning / MacFarlane, Marion / Peltzer, Nieves / Annibaldi, Alessandro

    Science advances

    2023  Volume 9, Issue 30, Page(s) eadg2829

    Abstract: Cell death coordinates repair programs following pathogen attack and tissue injury. However, aberrant cell death can interfere with such programs and cause organ failure. Cellular FLICE-like inhibitory protein (cFLIP) is a crucial regulator of cell death ...

    Abstract Cell death coordinates repair programs following pathogen attack and tissue injury. However, aberrant cell death can interfere with such programs and cause organ failure. Cellular FLICE-like inhibitory protein (cFLIP) is a crucial regulator of cell death and a substrate of Caspase-8. However, the physiological role of cFLIP cleavage by Caspase-8 remains elusive. Here, we found an essential role for cFLIP cleavage in restraining cell death in different pathophysiological scenarios. Mice expressing a cleavage-resistant cFLIP mutant,
    MeSH term(s) Animals ; Mice ; Caspase 8/genetics ; Apoptosis ; Skin/metabolism ; Tumor Necrosis Factor-alpha/metabolism ; Virus Diseases
    Chemical Substances Caspase 8 (EC 3.4.22.-) ; Tumor Necrosis Factor-alpha
    Language English
    Publishing date 2023-07-26
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2810933-8
    ISSN 2375-2548 ; 2375-2548
    ISSN (online) 2375-2548
    ISSN 2375-2548
    DOI 10.1126/sciadv.adg2829
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis.

    Fritsch, Melanie / Günther, Saskia D / Schwarzer, Robin / Albert, Marie-Christine / Schorn, Fabian / Werthenbach, J Paul / Schiffmann, Lars M / Stair, Neil / Stocks, Hannah / Seeger, Jens M / Lamkanfi, Mohamed / Krönke, Martin / Pasparakis, Manolis / Kashkar, Hamid

    Nature

    2019  Volume 575, Issue 7784, Page(s) 683–687

    Abstract: Caspase-8 is the initiator caspase of extrinsic ... ...

    Abstract Caspase-8 is the initiator caspase of extrinsic apoptosis
    MeSH term(s) Animals ; Apoptosis/genetics ; Caspase 8/genetics ; Caspase 8/metabolism ; Cell Line ; Cells, Cultured ; Enzyme Activation/genetics ; Gene Expression Profiling ; Gene Knockout Techniques ; HEK293 Cells ; Humans ; Inflammasomes/metabolism ; Intestinal Mucosa/cytology ; Intestinal Mucosa/enzymology ; Keratinocytes/cytology ; Keratinocytes/pathology ; Mice ; Mutation ; Necroptosis/genetics ; Pyroptosis/genetics ; Receptor, TIE-2/genetics ; Receptor, TIE-2/metabolism
    Chemical Substances Inflammasomes ; Receptor, TIE-2 (EC 2.7.10.1) ; Tek protein, mouse (EC 2.7.10.1) ; Caspase 8 (EC 3.4.22.-)
    Language English
    Publishing date 2019-11-20
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 120714-3
    ISSN 1476-4687 ; 0028-0836
    ISSN (online) 1476-4687
    ISSN 0028-0836
    DOI 10.1038/s41586-019-1770-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19.

    Theobald, Sebastian J / Simonis, Alexander / Georgomanolis, Theodoros / Kreer, Christoph / Zehner, Matthias / Eisfeld, Hannah S / Albert, Marie-Christine / Chhen, Jason / Motameny, Susanne / Erger, Florian / Fischer, Julia / Malin, Jakob J / Gräb, Jessica / Winter, Sandra / Pouikli, Andromachi / David, Friederike / Böll, Boris / Koehler, Philipp / Vanshylla, Kanika /
    Gruell, Henning / Suárez, Isabelle / Hallek, Michael / Fätkenheuer, Gerd / Jung, Norma / Cornely, Oliver A / Lehmann, Clara / Tessarz, Peter / Altmüller, Janine / Nürnberg, Peter / Kashkar, Hamid / Klein, Florian / Koch, Manuel / Rybniker, Jan

    EMBO molecular medicine

    2021  Volume 13, Issue 8, Page(s) e14150

    Abstract: Innate immunity triggers responsible for viral control or hyperinflammation in COVID-19 are largely unknown. Here we show that the SARS-CoV-2 spike protein (S-protein) primes inflammasome formation and release of mature interleukin-1β (IL-1β) in ... ...

    Abstract Innate immunity triggers responsible for viral control or hyperinflammation in COVID-19 are largely unknown. Here we show that the SARS-CoV-2 spike protein (S-protein) primes inflammasome formation and release of mature interleukin-1β (IL-1β) in macrophages derived from COVID-19 patients but not in macrophages from healthy SARS-CoV-2 naïve individuals. Furthermore, longitudinal analyses reveal robust S-protein-driven inflammasome activation in macrophages isolated from convalescent COVID-19 patients, which correlates with distinct epigenetic and gene expression signatures suggesting innate immune memory after recovery from COVID-19. Importantly, we show that S-protein-driven IL-1β secretion from patient-derived macrophages requires non-specific monocyte pre-activation in vivo to trigger NLRP3-inflammasome signaling. Our findings reveal that SARS-CoV-2 infection causes profound and long-lived reprogramming of macrophages resulting in augmented immunogenicity of the SARS-CoV-2 S-protein, a major vaccine antigen and potent driver of adaptive and innate immune signaling.
    MeSH term(s) COVID-19 ; Humans ; Immunity, Innate ; Inflammasomes ; Interleukin-1beta ; Macrophages ; NLR Family, Pyrin Domain-Containing 3 Protein/genetics ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus
    Chemical Substances Inflammasomes ; Interleukin-1beta ; NLR Family, Pyrin Domain-Containing 3 Protein ; Spike Glycoprotein, Coronavirus ; spike protein, SARS-CoV-2
    Language English
    Publishing date 2021-06-16
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2467145-9
    ISSN 1757-4684 ; 1757-4676
    ISSN (online) 1757-4684
    ISSN 1757-4676
    DOI 10.15252/emmm.202114150
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top